In a fascinating shift, researchers are investigating whether psychedelics like psilocybin and LSD might help regulate overactive immune responses—turning substances known for altering perception into potential therapeutic tools.

A new meta-analysis is examining the anti-inflammatory and immune-modulating properties of serotonergic psychedelics, as scientists worldwide explore their potential to treat mental health and brain-related disorders. This research represents a promising frontier in understanding how these compounds could address conditions rooted in immune system dysfunction. Read the full story →

Today's takeaway: What was once considered purely recreational may unlock new pathways for treating inflammation-based diseases.